Columbus Venture Partners — Full Portfolio
34 tracked investments · listed companies and verified rows first
Aura Biosciences develops Virus-Like Drug Conjugates (VDCs), a platform using Virus-Like Particles conjugated with drugs or loaded with nucleic acids to target solid tumors.
BiotechHealthtechMedical DevicesCambridge, US
Elisabet de los Pinos, Ph.D.(Executive Officer, Director)Elisabet de los Pinos(Founder)inMichael Wyzga(Executive Officer)Dale Pfost, Ph.D.(Director)Alan E. Walts, Ph.D.(Director)Lewis Geffen(Executive Officer)
PartnerJose Mesa· solo GP
Co-investorsAdvent Life SciencesChiesi VenturesDroia VenturesForesite CapitalJazzya InvestmentsMedicxi+4 more
Arthex Biotech develops antisense RNA compounds to treat diseases with unmet medical needs.
AI & Machine LearningBiotechMedical Devices
Beatriz Llamusí(Chief Scientific Officer & Co-Founder)in
PartnerJose Mesa· solo GP
Co-investorsBpifranceHadean VenturesSound BioventuresAdBio partnersInvivo Capital Partners
Quatre Lab is a Contract Research Organization specializing in quality control testing and validation of Advanced Therapy Medicinal Products (ATMPs) for biotech and pharmaceutical companies.
BiotechDeep TechHealthtechMedical DevicesSpain, ES
Patricia Muñoz(Managing Director)Columbus Venture Partners
PartnerJose Mesa· solo GP
Vivet Therapeutics is a clinical-stage biotechnology company developing recombinant adeno-associated virus (rAAV) gene therapies for rare, inherited metabolic diseases, including Wilson's Disease and cerebrotendinous xanthomatosis.
BiotechHealthtechParis, FR
PartnerJose Mesa· solo GP
Co-investorsHealthCapKurma PartnersNovartis Venture FundRoche Venture FundYsios CapitalEurazeo+1 more
Accipiter Biosciences uses computational protein design to develop de novo, single-agent protein therapies that engage multiple cell-surface receptors at once, functioning as agonists.
AI & Machine LearningBiotechDeep TechSeattle, US
Matthew Bick(Executive Officer, Director, Promoter)inJavier Castellanos(Executive Officer, Director, Promoter)Hector De Jesus Rincon Arano(Executive Officer, Promoter)Heather Redman(Director)Randall Schatzman(Director)William Canestaro(Executive Officer)
PartnerJose Mesa· solo GP
Co-investorsArgonautic VenturesPack VenturesWRF Capital
Alto Pharmacy is a full-service pharmacy that offers patients medication delivery, cost transparency, and pharmacist access.
ConsumerDigital HealthHealthtechSan Francisco, US
James Karraker(Executive Officer, Director)Mattieu Gamache-Asselin(Founder & CEO)inNichola Eliovits(Director)Nathaniel Kan(Director)Robert Spinner(Director)
PartnerJose Mesa· solo GP
Co-investorsAvego BioScience CapitalBantam GroupCalm VenturesCSC UpshotEvolution VC PartnersFlucas Ventures+8 more
Artax Biopharma is a Phase 2 clinical-stage biotechnology company developing first-in-class oral small-molecule Nck modulators that target T cell receptor Signal 1 activation to treat autoimmune diseases without causing immunosuppression.
BiotechHealthtechCambridge, US
Damia Tormo(President, CEO, Treasurer and Founder)inJoe Suarez(Executive Officer)Maria Nichol(Executive Officer)inRobert W. Armstrong, Ph.D.(Executive Officer, Director)Rob Armstrong(CEO)in
BoardAndre Hoekema(Director)
PartnerJose Mesa· solo GP
Co-investorsSound BioventuresAdvent Life Sciences
AskBio is a gene therapy company developing adeno-associated virus (AAV)-based genetic medicines for rare and other diseases, with clinical programs such as AB-1009 for late-onset Pompe disease.
BiotechDeep TechHealthtechDurham, US
PartnerJose Mesa· solo GP
Co-investorsTPGVida Ventures
Curapath is a European Contract Development and Manufacturing Organization (CDMO) specializing in polymer- and lipid-based non-viral drug delivery systems for biotech and pharmaceutical companies.
Advanced ManufacturingBiotechDeep TechHealthtechMedical Devices
Philippe(Chief Executive Officer)Vicent(Chief Technology Officer)
PartnerJose Mesa· solo GP
Curve Therapeutics uses its mammalian cell-based Microcycle discovery platform to develop cyclic peptide and small molecule drugs against intracellular targets.
AI & Machine LearningBiotech
PartnerJose Mesa· solo GP
Co-investorsEpidarex CapitalPfizer Venture Investments
Deepull develops a multiplex PCR diagnostic system to rapidly identify sepsis-causing pathogens and antibiotic resistance markers directly from blood samples in approximately one hour, targeting hospitals and clinical laboratories.
Medical Devices
Co-investorsAsabys Partners
A digital agency offering design and development services—including 3D space configuration, digitizing physical samples into online catalogs, and ticket-sales platforms—for brands across multiple sectors.
Marketing TechSaaS
Highlight Therapeutics is a biotech company developing therapeutic treatments.
BiotechHealthtech
Marisol Quintero(Chief Operating Officer (former CEO 2013-2025))in
PartnerJose Mesa· solo GP
Co-investorsDroia VenturesBuenavista Equity Partners
PartnerJose Mesa· solo GP
Co-investorsAdBio partnersInvivo Capital Partners
Jurata develops thermostable film-based formulations that allow vaccines and biologics to be stored and shipped without refrigeration and delivered without needles, including an intranasal film.
BiotechDeep TechHealthtechLogistics & Supply Chain
PartnerJose Mesa· solo GP
Lark develops an AI-powered health coaching platform that delivers personalized support for chronic disease prevention and management through 24/7 text-based conversations and integration with smart health devices.
AI & Machine LearningDigital HealthHealthtech
PartnerJose Mesa· solo GP
Co-investorsAlpha Intelligence CapitalAsset Management CompanyCrunchFundIPD CapitalJoyance PartnersKing River Capital+5 more
Minoryx is a registration-stage biotech company developing novel therapies for severe, orphan genetic diseases of the central nervous system, with a lead compound (leriglitazone) in clinical trials for conditions including cerebral adrenoleukodystrophy, Friedreich's Ataxia, and Rett syndrome.
BiotechDeep TechHealthtechMedical DevicesMataró, ES
Marc Martinell(Co-Founder & Chief Executive Officer)in
PartnerJose Mesa· solo GP
Co-investorsChiesi VenturesCriteria Bio VenturesFund+Invivo Capital PartnersKurma PartnersRoche Venture Fund+1 more
PartnerJose Mesa· solo GP
Co-investorsAdvent Life SciencesFountain Healthcare PartnersOrbiMed
Ona provides cloud-based agent infrastructure that runs developer tasks in isolated environments while laptops are closed, automating workflow execution through events, schedules, and pull requests.
AI & Machine LearningCloud ComputingDeveloper Tools
Co-investorsBright Pixel CapitalCrane Venture PartnersPebblebedPreston-Werner VenturesAlta Life SciencesKorys+1 more
WE ARE ONA is a creative culinary studio that designs bespoke dining experiences for luxury and artistic brands, combining strategy, design, and production to reinforce emotional connections between brands and their audiences.
ConsumerFoodTechMarketplacesParis, FR
Luca Pronzato(Founder)
Co-investorsWind VentureKorysMérieux Equity PartnersYsios Capital
Ona Therapeutics develops therapeutic antibodies targeting lipid metabolism to treat advanced and metastatic cancers, including liposarcoma.
BiotechHealthtechMedical Devices
Co-investorsFund+KorysMérieux Equity PartnersYsios CapitalAlta Life SciencesAsabys Partners+2 more
Quibim develops cloud-based AI software platforms for medical imaging analysis that extract radiomics features and generate predictive models for healthcare providers and biopharma companies.
AI & Machine LearningHealthtechMedical Devices
PartnerJose Mesa· solo GP
Co-investorsAdara VenturesAmadeus Capital PartnersAPEX VenturesLifeX VenturesAsabys PartnersGoHub Ventures
PartnerJose Mesa· solo GP
PartnerJose Mesa· solo GP
Artis BioSolutions is an integrated platform for genetic medicine that produces enzymatically synthesized synthetic DNA and develops it into clinical-grade advanced therapies with in-house GMP manufacturing.
Advanced ManufacturingBiotechMedical DevicesWatertown, US
PartnerJose Mesa· solo GP
Co-investorsBuenavista Equity Partners
TAAV is a contract development and manufacturing organization (CDMO) that produces neDNA, an enzymatic DNA technology that serves as an alternative to plasmid DNA for manufacturing recombinant adeno-associated viruses (rAAV) used in gene therapy.
BiotechDeep TechHealthtechMedical DevicesSan Sebastian, ES
PartnerJose Mesa· solo GP
Tolerance is a compliance platform that runs continuous automated checks against the NIST 800-171 standard and collects assessor-ready evidence for teams handling Controlled Unclassified Information (CUI).
CybersecurityGovTechSaaS
Co-investorsDorm RoomAmadeus Capital PartnersBen Franklin Technology PartnersBioAdvanceCriteria Bio VenturesEast Innovate+4 more
Tolerance Bio develops therapeutics targeting the thymus—the regulator of immune tolerance—to preserve, restore, and manipulate its function and extend health span.
BiotechDeep TechLongevityPhiladelphia, US
Francisco Leon(Executive Officer, Director)inPhilip Ball(Executive Officer, Director)Justin Vogel(Executive Officer, Director)in
BoardDamia Tormo Carulla(Director)Pablo Cironi(Director)inRobert Goldstein(Director)
Co-investorsCriteria Bio VenturesBen Franklin Technology PartnersBioAdvance
Viralgen provides contract manufacturing services for AAV-based gene therapy, supporting early-phase preclinical and clinical production with a platform designed for regulatory compliance and batch scalability.
Advanced ManufacturingBiotechDeep TechHealthtechMedical DevicesSan Sebastián, ES
Jimmy Vanhove(CEO)
PartnerJose Mesa· solo GP
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.